Pediatric Interventional Cardiology Market to Grow with a CAGR of 6.72% through 2030F
The rising incidence of congenital heart diseases, the
widespread adoption of minimally invasive techniques, and technological
innovations are expected to drive the Global Pediatric Interventional
Cardiology Market growth in the forecast period, 2026-2030F
According to TechSci Research report, “Pediatric
Interventional Cardiology Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global
Pediatric Interventional Cardiology Market stood at USD 2.41 billion in 2024
and is anticipated to grow with a CAGR of 6.72% in the forecast period. This can be attributed to research and clinical trials. Ongoing
research and clinical trials are vital factors driving the pediatric
interventional cardiology market. These studies continually refine existing
procedures and explore new interventions, ensuring that the field remains at
the forefront of pediatric cardiac care. Patients and practitioners benefit
from evidence-based advancements in treatment options.
The research in gene therapy and regenerative medicine holds
promise for treating congenital heart diseases at the genetic level. While
still in the experimental phase, these approaches may become more prominent in
the future. The pediatric interventional cardiology market was significantly impacted by the COVID-19 pandemic. Numerous global investigations have documented a decrease in hospitalizations and cardiac procedures during this period. For instance, an article published on PubMed in August 2022 highlighted the substantial impact of the pandemic on the provision of pediatric cardiac care in India, resulting in a two-thirds reduction in hospitalizations and cardiac surgeries. However, with the pandemic now waning, hospitals have resumed their standard procedures. Consequently, the studied market is anticipated to experience stable growth throughout the forecast period of the study.
Market expansion is expected to be driven by factors such as an increasing incidence of heart disease and rapid technological advancements. The most prevalent congenital condition is congenital heart defects (CHD). Ventricular septal defect (VSD) is the most common heart defect in newborns. Consequently, the rising prevalence of CHD is projected to drive the adoption of pediatric interventional cardiology devices.
The introduction of new products and strategic initiatives by major market players is positively influencing market growth. For instance, in July 2021, Abbott launched an occluder, a self-expanding wire mesh device that can be inserted through a small incision in the leg and navigated through vessels to the heart. Here, it is positioned to seal heart openings, particularly to treat patent ductus arteriosus (PDA). Remarkably, this device can be implanted in even the smallest infants, weighing as little as 700 grams, using a minimally invasive procedure.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Pediatric Interventional Cardiology Market”
The Global Pediatric Interventional Cardiology Market is
segmented into device type, procedure, regional distribution, and company.
Based on its device type, Transcatheter Heart Valves are the
fastest-growing category in the global Pediatric Interventional Cardiology
Market. This rapid growth is driven by advancements in minimally invasive valve
replacement technologies, which offer safer alternatives to open-heart
surgeries, especially in children with congenital heart defects. The increasing
prevalence of pediatric valve disorders, such as aortic or pulmonary valve
abnormalities, has further fueled demand for these devices. The growing success of transcatheter aortic valve
replacement (TAVR) in adults has led to expanded research and adaptation of
these technologies for pediatric use. Improved device miniaturization and
growing clinical evidence supporting their efficacy in children contribute to
their rising adoption. Hospitals and cardiology centers are increasingly
equipped with advanced imaging and catheterization labs, enabling more precise
and less invasive interventions. These factors collectively make Transcatheter
Heart Valves the most dynamic and rapidly expanding segment in pediatric
interventional cardiology worldwide.
Based on procedure, Among the listed procedures,
Catheter-Based Valve Implantation is the fastest-growing segment in the global
Pediatric Interventional Cardiology Market. This growth is driven by its
minimally invasive nature, offering significant advantages over traditional
open-heart surgeries, especially for pediatric patients. The procedure involves
implanting or replacing heart valves using catheters, reducing surgical risks,
shortening hospital stays, and minimizing recovery times. Such benefits are particularly
crucial for children, who are more vulnerable to the complications associated
with invasive surgeries. Advancements in medical technology have enhanced the
precision and safety of catheter-based valve implantation. The development of
pediatric-specific devices and imaging techniques has made the procedure more
accessible and effective. The increasing prevalence of congenital heart
diseases requiring valve interventions has heightened the demand for this less
invasive option. Healthcare providers and parents are increasingly opting for
catheter-based solutions due to their efficacy and reduced trauma to young
patients. As a result, this segment is experiencing substantial revenue growth
and is poised to continue its upward trajectory in the coming years.
Major companies operating in Global Pediatric
Interventional Cardiology Market are:
· Abbott Laboratories Inc
· Biotronik Inc
· Boston Scientific Corporation
· Canon Medical Systems Corp
· Cardinal Health Inc
· Cordis Corp
· Edwards Lifesciences LLC
· GE Healthcare Inc
· Medtronic Inc
· Siemens Healthineers AG
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“The Global Pediatric Interventional Cardiology Market is
poised for significant advancements in the coming years, driven by the emerging
trends. As technology continues to evolve and our understanding of pediatric
cardiac care deepens, children with heart conditions stand to benefit from more
precise, less invasive, and personalized interventions. The collective efforts
of healthcare providers, researchers, and innovators worldwide are shaping a
future where pediatric cardiac care is more effective and patient-centric than
ever before”, said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Pediatric Interventional Cardiology Market, By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others), By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth
potential of Global Pediatric Interventional Cardiology Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Pediatric Interventional Cardiology
Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com